Targeting unique metabolic pathways in pathogens offers a novel approach to precision antibiotics, addressing the growing challenge of antimicrobial...
Vous n'êtes pas connecté
A recent study has made significant strides in uncovering how the oral microbiome, particularly the bacterium Fusobacterium nucleatum, plays a crucial role in the progression of oral squamous cell carcinoma (OSCC). By identifying key interactions between this common oral bacterium and host cells, the research has unveiled important metabolic pathways and mechanisms that may serve as potential therapeutic targets.
Targeting unique metabolic pathways in pathogens offers a novel approach to precision antibiotics, addressing the growing challenge of antimicrobial...
Oesophageal squamous cell carcinoma (ESCC) is a severe health threat, being a predominant subtype of oesophageal cancer and contributing significantly...
A recent study suggests that metformin, a widely prescribed medication for type 2 diabetes, may reduce the risk of developing certain types of skin...
Announcing a new publication for Acta Materia Medica journal. Epithelial cell adhesion molecule (EpCAM) is a biomarker for epithelial cell-derived...
Analysis of gut microbiomes reveals co-colonization patterns and potential therapeutic targets against Enterobacteriaceae, addressing global health...
How does obesity influence cancer risk? This analysis explores the hormonal, inflammatory, and microbiome pathways driving obesity-related...
Since its discovery in the 1990s, “programmed cell death protein 1,” or PD-1, has been regarded as a leading target in cancer treatments. A...
TUESDAY, Jan. 14, 2025 -- A popular diabetes drug can provide protection against skin cancers, a new study says. Metformin significantly reduces...
TUESDAY, Jan. 14, 2025 -- A popular diabetes drug can provide protection against skin cancers, a new study says.Metformin significantly reduces...
In a monumental breakthrough in cancer research, a team of scientists from South Korea has unveiled a revolutionary technology that may turn cancerous...